Louis Shamel
Pricing Strategy & Analytics Consultant | Lasting Improvements to Commercial Decision-Making at Scale
Pricing strategy and analytics consultant specializing in high-SKU, high-transaction commercial environments. I help organizations build lasting improvements to how pricing decisions are made, delivering sophisticated analytics systems calibrated to the client's commercial context, end-to-end, from strategy through deployment. With deep roots in life sciences and enterprise-scale pricing operations, I bring both domain credibility and technical execution to engagements that require more than a slide deck. Everything I build is designed to be owned, operated, and extended by the client's team.
With a scientific background spanning hands-on laboratory research through graduate-level study of the life sciences business, I bring an uncommon contextual understanding of the products being priced, how they're used, how they perform relative to alternatives, and what that means for customer decision-making and pricing strategy.
Core Competencies
Career History
-
Louis Shamel Consulting — Principal (June 2024–Present)
Client: Genesee Scientific — Primary pricing strategy and analytics resource for finance, marketing, and sales teams. Led pricing and margin optimization initiatives within a distribution environment, supporting finance and sales with price performance reporting, profitability analytics, and annual/intra-year pricing actions. Developed proprietary price-scraping platform to establish price history database and inform competitive decision-making.
-
Thermo Fisher Scientific — Sr. Director, Global Strategic Pricing (October 2020–April 2024)
Co-head of the Global Strategic Pricing function overseeing pricing strategies for $5–10B life sciences segments. Led development and operation of enterprise pricing and profitability decision systems using technology-enabled processes and data-driven insights. Partnered with data science, IT, and analytics teams to define and deliver pricing technology roadmap, including digital solutions supporting revenue growth, margin optimization, and deal execution.
-
Thermo Fisher Scientific — Director, Global Strategic Pricing (February 2017–October 2020)
Deployed web platform to coordinate annual list price renewal alignment globally across four divisions. Developed and executed dynamic price recommendation system integrated into Salesforce CPQ quoting workflow.
-
Thermo Fisher Scientific — Sr. Manager, Global Strategic Pricing (July 2015–February 2017)
Led team of 4 pricing analysts executing pricing strategies for the Bioscience Division globally and all divisions in North America. Drove implementation of best practices supporting $33M global price attainment for Biosciences and $39M in North America in 2016.
-
Thermo Fisher Scientific — Lead Analyst & Manager, M&A (2010–2015)
Led and supported domestic and international M&A transactions ranging from $1M to $1.5B, including financial modeling, business case development, and executive reporting. Managed cross-functional due diligence and integration planning across finance, operations, IT, HR, legal, and commercial teams.
-
Earlier Life Sciences Roles
Research and business development positions at Scripps Research Institute, Gen-Probe, Illumina, The Salk Institute, and Althea Technologies—spanning genetics, bioinformatics, product development, and portfolio analytics.
Pricing complexity costing you margin?
If you're dealing with high SKU counts, high transaction volumes, or both — let's talk about what it's costing you and what can be done about it.
Book a 30-minute intro